Trendlines Group Ltd. · SGX:42T
Trendlines — The Trendlines Group — Shareholder Meeting (April 2018)
29 slides from Trendlines's shareholder meeting presentation, Apr 25, 2018
Slide 1: Results of the Annual General Meeting
THE TRENDLINES GROUP LTD. (Incorporated in Israel) (Company Registration No. 513970947) RESULTS OF THE ANNUAL GENERAL MEETING The Board of Directors (the “Board”) of The Trendlines Group Ltd. (the “Company”) wishes to announce that at its Annual General Meeting (the "AGM") held on 25 April 2018, the
Slide 2: Abstentions, scrutineer and sponsor statement
(b) Details of parties who are required to abstain from voting on any resolutions: No party is required to abstain from voting on any resolution put to vote at the AGM. (c) Name of firm and/or person appointed as scrutineer: Lee Lih Feng of DrewCorp Services Pte Ltd was appointed as scrutineer of th
Slide 3: About The Trendlines Group: Highlights from 2017 and a focus on 2018
About The Trendlines Group Highlights from 2017 and a focus on 2018 Annual General Meeting April 2018 SGX:42T OTCQX: TRNLY
Slide 4: Legal disclaimer
Legal disclaimer Important notice This presentation is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any securities of The Trendlines Group Ltd. (“Company”) or any of its portfo
Slide 5: About Trendlines
About Trendlines
Slide 6: Trendlines: building companies, commercializing innovation
Trendlines: building companies, commercializing innovation Trendlines establishes, develops, invests in, and supports technology-based medical and agricultural companies to improve the human condition. 4
Slide 7: Trendlines: building companies, commercializing innovation (life science incubators)
Trendlines: building companies, commercializing innovation Life science incubators 5
Slide 8: Trendlines: building companies, commercializing innovation (innovation center)
Trendlines: building companies, commercializing innovation In-house innovation center of The Trendlines Group Inventing and developing technologies to address unmet market needs 6
Slide 9: Management: Decades of company-building experience
Management: Decades of company-building experience Nitza Kardish, Ph.D. Todd Dollinger VP The Trendlines Group Yosi Hazan Chairman & CEO CEO Trendlines Incubators Israel VP The Trendlines Group CEO Trendlines Labs Eric Loh CEO Trendlines Medical Singapore Steve Rhodes Chairman & CEO Gabi Heller Mosh
Slide 10: Key developments of 2017
Key developments of 2017
Slide 11: Key corporate developments FY 2017
Key corporate developments FY 2017 • Trendlines Medical Singapore Pte. Ltd. launched and invested in first company • Trendlines raised US$10.3 million of gross proceeds in new shares placement • Trendlines Labs’ agreement with Singapore General Hospital and grant from the Singapore Israel Industrial
Slide 12: Key portfolio company developments FY 2017
Key portfolio company developments FY 2017 • Nine new companies established (8 in Israel, 1 in Singapore) • New company established under Bayer Trendlines Ag Innovation Fund (IBI-Ag Ltd.) • 15 portfolio companies raised over US$20 million in follow-on investments – 4 from strategic partners • Three
Slide 13: Q1 developments
Q1 developments • Disclosure of Stimatix GI Ltd. as Most Valuable Portfolio Company (“MVP”) and acquirer as B. Braun Medical SAS • Trendlines Medical Singapore Pte. Ltd. and K2 Global Pte. Ltd. to participate in a government-backed SGD100 million start-up program by SPRING SEEDS Capital Pte. Ltd. •
Slide 14: Key financial developments
Key financial developments
Slide 15: 10 years of portfolio value expansion
10 years of portfolio value expansion US$ millions Portfolio value with exit proceeds 140 120 Portfolio value* 100 Cumulative exit proceeds 80 60 40 20 0 30.12.08 30.12.09 30.12.10 30.12.11 31.12.12 31.12.13 31.12.14 31.12.15 31.12.16 31.12.17 *Portfolio value includes the fair value of investments
Slide 16: Key financial developments FY2017
Key financial developments FY2017 31 December 31 December Change % Change 2017 2016 Portfolio value US$96.8 million US$83.7 million + US$13.1 million + 16% Net gain/loss US$3.9 million (US$6.6 million) + US$10.5 million N/A Book value US$92.2 million US$78.2 million + US$14.0 million + 18% Current a
Slide 17: Consolidated condensed report of income
Consolidated condensed report of income 15
Slide 18: Key value components
Key value components Change in portfolio value during year Balance sheet (US$ millions) 20.4 (3.8) (7.8) (5.3) 16.4 (13.8) 4.5 (1.4) 83.7 96.8 92.9 Net portfolio Investments and Fair value Fair value Net portfolio Cash, short-term Fair value of Deferred Deferred tax** Payables & Total equity value 3
Slide 19: 10 Companies to Watch
10 Companies to Watch
Slide 20: 10 companies (+1) to watch
10 companies (+1) to watch* • ApiFix Ltd. • Leviticus Cardio Ltd. • BioFishency Ltd. • MemTech Ltd. • EdenShield Ltd. • Saturas Ltd. • Fidmi Medical Ltd. • STS Medical Ltd. • Gordian Surgical Ltd. • Vensica Medical Ltd. +1 Stimatix GI Ltd. *Updated report issued: 23 April 2018 18
Slide 21: Low-profile solutions for colostomy management
Low-profile solutions for colostomy management Development of low-profile innovative solutions for colostomy management, created to improve the quality of life for people with stomas. Achievements • Multiple successful clinical studies completed • Received CE and FDA approval within 3 years Status •
Slide 22: Water treatment system for aquaculture
Water treatment system for aquaculture Cost-effective, all-in-one water treatment system for reduced water use and improved yields in all types of land- based aquaculture systems Recent developments • 2017 sales of US$550,000; 2018 Q1 sales of US$800,000 • Signed term sheet with the Technion Researc
Slide 23: A breakthrough in heart pump technology
A breakthrough in heart pump technology Wireless system provides constant power needs of heart pump (LVAD) implants to eliminate complications related to drive line cables Recent developments • Animal trial with successful 60+ day follow-up • Raised US$8.7 million to date Status • Fully operational
Slide 24: Miniature stem water potential (SWP) sensor
Miniature stem water potential (SWP) sensor Optimized irrigation through a miniature SWP sensor embedded in the trunks of trees, vines, and plants Recent developments • Completed an investment round of US$4 million • Completed successful field trials in commercial almond, citrus and apple orchards (
Slide 25: Upcoming events
Upcoming events
Slide 26: AgriVest 2018
AgriVest 2018 8 May 2018 | Tel Aviv, Israel www.agrivestisrael.com 24
Slide 27: MIXii Biomed 2018
MIXii Biomed 2018 15 -17 May 2018 | Tel Aviv, Israel http://kenes-exhibitions.com/biomed/ 25
Slide 28: Contact: Steve Rhodes, Gabi Heller
SGX: 42T Steve Rhodes, Chairman & CEO OTCQX: TRNLY steve@trendlines.com +972.72.260.7000 Gabi Heller, CFO www.trendlines.com gabi@trendlines.com 25 April 2018
Slide 29: SGX announcement details: Annual General Meeting
Issuer/Manager THE TRENDLINES GROUP LTD. Securities THE TRENDLINES GROUP LTD. – IL0011328858 – 42T Stapled Security No Announcement Title Annual General Meeting Date & Time of Broadcast 25-Apr-2018 20:57:17 Status New Narrative Type Results of the Annual General Meeting Meeting Date, Time and 25/04/
The Trendlines Group — Shareholder Meeting (April 2018) on 6ix